You are here
Sanofi to pay US$11.9m to resolve US drug kickback probe
[BOSTON] Sanofi SA has agreed to pay nearly US$11.9 million to resolve allegations that it used a charity that helps Medicare patients cover out-of-pocket drug costs as a way to pay kickbacks aimed at encouraging the use of a high-priced multiple sclerosis drug.
The US Justice Department on Friday said Sanofi was the latest company to settle claims stemming from an industry-wide probe of drugmakers' financial support of patient assistance charities.
Sanofi did not admit wrongdoing as part of the settlement.